SPOTLIGHT -
Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.
Positive Phase 2 Data for NBI-1065845 in Adults With Major Depressive Disorder
Blue Light Blockers: A Behavior Therapy for Mania
NeuroStar TMS and the Future of MDD Treatment for Adolescents
Treating ‘Morally Objectionable’ Patients
Treatment-Resistant Geriatric Depression: Augmenting or Switching an Antidepressant
New Phase 3 Study Results on Lumateperone, An Adjunctive Therapy to Antidepressants